Phase 1 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People between 18 and 80 years of age
- People who have a confirmed diagnosis of chronic kidney disease (CKD), with kidney function test results falling within a specific range (eGFR between 15 and 89 mL/min/1.73 m²)
- People who are open to trying experimental treatments and are willing to follow all study requirements
- People who are able to have the required blood tests done
- People who are able to attend all scheduled appointments for the study
- People who are able to pay a study participation fee of $15,000, as outlined in the study consent documents
Who may not be able to join:
- People who have severe allergies to the products used in the study
- People who have significant medical conditions that are not well controlled
- People whose immune system is weakened or suppressed
- People who have a history of cancer
- People whose medications have been frequently changed or who have regularly missed doses in the 30 days before the study starts (assessed at the trial doctor's discretion)
- People who are currently receiving dialysis (either hemodialysis or peritoneal dialysis), or who are expected to start dialysis during the study period
- People who are pregnant or breastfeeding (where applicable)
- People who have taken part in another interventional clinical trial within the past 30 days
- People who have previously had a kidney transplant
- People who have at any point received stem cell therapy (including treatments involving umbilical cord blood-derived stem cells or exosomes) or glutathione therapy (whether given by injection or applied to the skin)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Richard Edwards, DO, Adia Med of Winter Park LLC
Phone: 3217880850
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from Baseline in Estimated Glomerular Filtration Rate (eGFR); Change from Baseline in Serum Creatinine
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.